Thompson Davis & Co., Inc. Chimerix Inc Transaction History
Thompson Davis & Co., Inc.
- $132 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$30.4 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$15 Million0.0% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.6 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8.29 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.64 Million0.03% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $303M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...